Antidepressant Therapy in Patients with Cancer: A Clinical Review

Shen-Chieh Chang ； Winston W. Shen

《台灣精神醫學》 33卷1期 (2019/03) Pp. 13-19

https://doi.org/10.4103/TPSY.TPSY_3_19

摘要

Background: The prevalence of major depressive disorder (MDD) by DSM criteria among cancer patients is about 14%-15% in oncological, hematological, and palliative services and the number is risen up to 20%-25% when other depressive disorders are also included. Like MDD patients in general, patients with cancer are thought to be underdiagnosed and undertreated. Untreated depression in cancer patients may lead to having distressed symptoms and signs, decreased quality of life, higher suicide risk, greater psychological burden on the family, longer hospital stays, poorer anticancer treatment compliance, as well as even increased risk for mortality. Methods: In this review, the authors reviewed published articles on the use of antidepressant use for patients with cancer, to familiarize the readers with the use of antidepressants. Results: Antidepressants have been found to be more effective than placebo in relieving depressive symptoms in patients with cancer, and the efficacy is positively associated with length of treatment. Although the rate of antidepressant prescription is increasing, still about 75% of cancer patients with depression have not yet received antidepressant treatment. Besides the use in treating mood and anxiety symptoms, antidepressants have also been found to have versatile rôles as palliative treatment for cancer‑related symptoms - pain, hot flushes, nausea, anorexia/cachexia, and fatigue. Furthermore, antidepressants have been studied for their anticancer potentials. They can inhibit tumor growth through either indirectly regulating immunity by enhancing cytotoxic activity and modulating cytokine production, or directly initiating cancer cell death and arresting cancer cell proliferation. We also found important drug-drug interaction between antidepressants and tamoxifen. Conclusion: Besides treating depressive and anxiety disorders, antidepressants are effective in treating cancer-related symptoms (pain, hot flushes, nausea, anorexia/cachexia, and fatigue). Cancer patients are eager to receive more effective treatment against their cancer as well as comorbid depression, and physicians should be more aggressive in providing every beneficial regimen - including an antidepressant.

關鍵字

Anorexia/cachexia ； fatigue ； nausea ； pain

參考文獻

Mitchell AJ, Chan M, Bhatti H, et al.: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-74.

Walker J, Hansen CH, Martin P, et al.: Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 2014; 1: 343-50.

Chochinov HM: Depression in cancer patients. Lancet Oncol 2001; 2: 499-505.

Brenne E, Loge JH, Kaasa S, et al.: Depressed patients with incurable cancer: which depressive symptoms do they experience? Palliat Support Care 2013; 11: 491-501.

Chochinov HM, Wilson KG, Enns M, et al.: “Are you depressed?” screening for depression in the terminally ill. Am J Psychiatry 1997; 154: 674-6.